What is it about?
Graft versus host disease (GVHD) is a rare complication of solid organ transplantation, but occurs in 8-10% of recipients of a multivisceral transplant. Published data on how to look after patients with GVHD is conflicted, especially with regards to how to manage immunosuppression during this time. We show that reducing immunosuppression , at least initially, is associated with a better outcome and resolution of the GVHD.
Featured Image
Why is it important?
GVHD is a serious complication of multivisceral transplantation. The information contained in this publication should help clinicians looking after patients with this problem.
Perspectives
Read the Original
This page is a summary of: Graft versus host disease after multivisceral transplantation: A UK center experience and update on management, Clinical Transplantation, April 2018, Wiley,
DOI: 10.1111/ctr.13239.
You can read the full text:
Contributors
The following have contributed to this page